IPCI Stock DD Intellipharmaceutics International Inc. Sunday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
IPCI Intellipharmaceutics International Inc. $IPCI Company Overview

Stock Message Board http://investorshangout.com/search?q=IPCI&...mp;yt1=Go!

Last Updated: Sunday, April 13, 2014 5:48:20 PM

Intellipharmaceutics International Inc. IPCI Current Price and Quotes
Last Price 3.77
Previous Close 4.03 Open 4.00
Daily Range 4.02 - 3.70 52wk Range 6.46 - 1.50
Volume 521,423 Dividend N/A
Average Vol (3m) 585,061 Yield N/A
Intellipharmaceutics International Inc. IPCI

Intellipharmaceutics International Inc. IPCI
Intellipharmaceutics International Inc. IPCI

Intellipharmaceutics International Inc. IPCI


Intellipharmaceutics International Inc. IPCI Financials
Period Ending Nov 30, 2013 Nov 30, 2012 Nov 30, 2011 Nov 30, 2010
Total Revenue 1,527 107 502 1,459
Cost of Revenue - - - -
Gross Profit 1,527 107 502 1,459
Operating Expenses

Research and Development 5,076 5,992 5,126 4,533
Sales, General and Admin. 2,873 3,672 2,925 2,699
Non-Recurring Items - 107 - 36
Other 397 452 227 243
Operating Income (6,819) (10,117) (7,777) (6,052)
Income From Continuing Operations

Add'l Income/Expense Items (4,246) 4,044 5,338 390
Earnings Before Interest and Tax (11,065) (6,073) (2,439) (5,663)
Interest Expense 430 63 2,441 98
Earnings Before Tax (11,495) (6,137) (4,880) (5,761)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (11,495) (6,137) (4,880) (5,761)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (11,495) (6,137) (4,880) (5,761)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (11,495) (6,137) (4,880) (5,761)

Intellipharmaceutics International Inc. IPCI Recent News

Mar 21, 2014 Reviewing the Top Health Care Equities -- Research on IntelliPharmaCeutics, Delcath Systems, Valeant Pharma and Alkermes
Mar 19, 2014 Intellipharmaceutics -- Amended Form of Proxy for Shareholders Meeting to be Held on March 27, 2014
Mar 17, 2014 Correction - Mackie Research Capital Initiates Coverage on Intellipharmaceutics Intl (NASDAQ:IPCI) (TSX:I) with a Speculative Buy Recommendation - Video Research Alert on InvestmentPitch.com
Mar 14, 2014 Jennings Capital Initiates Coverage on Intellipharmaceutics Intl (NASDAQ:IPCI) (TSX:I) with a Speculative Buy Recommendation - Video Research Alert on InvestmentPitch.com
Mar 13, 2014 Approvals, Clinical Trial Results, Stock Summaries, Data Publication and Conference Participation - Analyst Notes on Northwest, La Jolla Pharma, Merrimack Pharma, Rosetta, and IntelliPharmaCeutics
Mar 4, 2014 Intellipharmaceutics to Present at Two Upcoming Investor Conferences
Feb 18, 2014 Intellipharmaceutics Announces 2013 Year End Results
Feb 4, 2014 Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market
Feb 3, 2014 Intellipharmaceutics Receives $3.1 Million From Par Pharmaceuticals, Inc.


IPCI Intellipharmaceutics International Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=IPCI&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/IPCI/quote
Stock Chart http://www.otcmarkets.com/stock/IPCI/chart
Company Info http://www.otcmarkets.com/stock/IPCI/company-info
Recent News http://www.otcmarkets.com/stock/IPCI/news
Financials http://www.otcmarkets.com/stock/IPCI/financials
Filings and Disclosure http://www.otcmarkets.com/stock/IPCI/filings
Short Sales http://www.otcmarkets.com/stock/IPCI/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/IPCI/insider-transactions
Research Reports http://www.otcmarkets.com/stock/IPCI/research
Summary http://finance.yahoo.com/q?s=IPCI
Historical Prices http://finance.yahoo.com/q/hp?s=IPCI+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=IPCI
Basic Chart http://finance.yahoo.com/q/bc?s=IPCI+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=IPCI+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=IPCI+Headlines
Press Releases http://finance.yahoo.com/q/p?s=IPCI+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=IPCI+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=IPCI+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=IPCI+Industry
Major Holders http://finance.yahoo.com/q/mh?s=IPCI+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=IPCI+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=IPCI+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=IPCI
Balance Sheet http://finance.yahoo.com/q/bs?s=IPCI
Cash Flow http://finance.yahoo.com/q/cf?s=IPCI+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/IPCI
Market Watch http://www.marketwatch.com/investing/stock/IPCI
Bloomberg http://www.bloomberg.com/quote/IPCI:US
Morningstar http://quotes.morningstar.com/stock/s?t=IPCI
Bussinessweek http://investing.businessweek.com/research/st...icker=IPCI
Barchart http://www.barchart.com/quotes/stocks/IPCI
OTC Short Report http://otcshortreport.com/index.php?index=IPCI
Investopedia http://www.investopedia.com/markets/stocks/IPCI/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 510

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 341

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 510

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 475

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 128

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 105

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 65

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
China, Europe, Africa Team Up for Green Energy Push

Updated Category News Views 107

The Need for Unity in a Warming World Some folks out there might be scratching their heads, wondering what sparks are flying between China, Europe, and Africa this time. Well, during the 2026 China-Europe-Africa Green Energy Development Forum held in sunny Zhejiang, the theme was loud and clear: We've got to deepen green partnerships to build a zero-carbon future. They're...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 77

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 745

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Penns Woods Banco Achieves New Stock Milestone of $24.25

Updated Category News Views 69

Penns Woods Banco Hits a 52-Week High Stock Price Penns Woods Banco Inc. (PWOD) has recently made headlines in the financial world by reaching a notable milestone with its stock price hitting a 52-week high of $24.25. This achievement is more than just a number; it represents a significant accomplishment for the regional bank holding company, which has witnessed a...

Continue Reading
Deep Dive into Recent Trends in Wolfspeed's Short Selling Landscape

Updated Category News Views 690

Wolfspeed’s Short Interest Is Climbing Wolfspeed (WOLF) has seen a clear pickup in short interest, rising 12.72% since the last read. The latest tally shows 24.14 million shares sold short, equal to 26.5% of the shares available to trade. One more useful measure: at current trading volumes, it would take about 5.76 days on average for short sellers to buy back those...

Continue Reading
Google Integrates SandboxAQ's Powerful AI for Quantum Progress

Updated Category News Views 173

Google Collaborates with SandboxAQ for Advanced AI Models In an exciting development in the realm of artificial intelligence, Google Cloud has partnered with SandboxAQ, a distinguished quantum startup. This collaboration aims to enhance Google's cloud services by integrating SandboxAQ's large quantitative models (LQMs), designed to manage extensive numerical data, execute...

Continue Reading
Will Gold Soar Further? Analyzing Market Influences

Updated Category News Views 154

Gold Grows Despite the Higher-Than-Expected US CPI Data Gold experienced a notable upswing, reversing its previous bearish trend during a trading session influenced by rising US inflation data. The XAU/USD pair gained 0.87% even as the US dollar saw strength from the latest Consumer Price Index (CPI) report. Market dynamics such as geopolitical uncertainty and...

Continue Reading
NRx Pharmaceuticals Engages Investors at Global Conference

Updated Category News Views 129

NRx Pharmaceuticals Shares Insights at Investment Conference Wilmington, Delaware — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a dedicated clinical-stage biopharmaceutical company focused on groundbreaking treatments, is set to participate in an engaging fireside chat at the highly anticipated H.C. Wainwright's 27th Annual Global Investment Conference. Event Details and...

Continue Reading